Urovant Sciences Ltd. UROV
— —
Day range unavailable
52-week range unavailable
Analyst view
Consensus: hold
Hold
Price target (mean) 16.17
- Target (low)
- 16.00
- Target (mean)
- 16.17
- Target (high)
- 16.25
Ratings (0m) 3 3 buy · 0 hold · 0 sell
- Strong buy1
- Buy2
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 3
- 1 month ago 3
- 2 months ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | -1.68 | 0.0% | 3.93M | 0.0% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | -0.99 | 0.0% | 8.30M | 0.0% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 3.93M | 0.0% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 67.57M | +1619.3% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 16, 2020 | JP Morgan | Downgrade | Overweight | Neutral |
| Nov 16, 2020 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Nov 13, 2020 | Jefferies | Downgrade | Buy | Hold |
| Jun 19, 2020 | HC Wainwright & Co. | Maintained | — | Buy |
| Dec 31, 2019 | H.C. Wainwright | Maintained | — | Buy |
| Mar 15, 2019 | SunTrust Robinson Humphrey | Initiated | — | Buy |
| Mar 11, 2019 | H.C. Wainwright | Initiated | — | Buy |
| Oct 22, 2018 | JP Morgan | Initiated | — | Overweight |
| Oct 22, 2018 | Jefferies | Initiated | — | Buy |
